NCT01607190View on ClinicalTrials.gov

Biomarkers of Diabetic Retinopathy Progression

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

April 30, 2016

Study Completion Date

December 31, 2017

Conditions
Type 2 Diabetes MellitusMild Nonproliferative Diabetic Retinopathy
Trial Locations (2)

500 034

LV Prasad Eye Institute, Hyderabad

3000-548

AIBILI- Association for Biomedical Research and Inovation on Light and Image., Coimbra

All Listed Sponsors
lead

Association for Innovation and Biomedical Research on Light and Image

OTHER

NCT01607190 - Biomarkers of Diabetic Retinopathy Progression | Biotech Hunter | Biotech Hunter